Real-World Treatment Patterns & Characteristics of Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Retrospective Analysis of US Claims (2017-2024)

被引：0
|
作者：
Burke, John M. [1 ,2 ]
Zhou, Ziqi [3 ]
Gutierrez, Cynthia [3 ]
Shao, Anran [4 ]
Boyd, Marley [4 ]
Noshad, Sina [3 ]
Hohlbauch, Andriana [3 ]
Liu, Nicholas [5 ]
Repetny, Karen [5 ]
Fanale, Michelle [5 ]
Mitchell, Betsy [5 ]
Phillips, Tycel [6 ]
机构：
[1] Sarah Cannon Res Inst, Aurora, CO USA
[2] Rocky Mt Canc Ctr, Aurora, CO USA
[3] Genesis, Hoboken, NJ USA
[4] Genesis Res Grp, Hoboken, NJ USA
[5] Pfizer, New York, NY USA
[6] City Of Hope, Dept Hematol & Oncol, Duarte, CA USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203554
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7810 / 7811
页数：2
相关论文
共 50 条
  • [41] Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database
    Peter Borchmann
    Jan-Michel Heger
    Jörg Mahlich
    Michael S. Papadimitrious
    Sybille Riou
    Barbara Werner
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7091 - 7101
  • [42] POD24 in Mexican Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Real-World Experience with Long Follow-up
    Candelaria, Myrna
    Aviles, Alejandro
    Gutierrez, Olga
    Castillo, Jorge J.
    BLOOD, 2024, 144 : 7816 - 7816
  • [43] Diffuse large B-cell lymphoma in elderly patients: A retrospective analysis
    Diem, S.
    Ess, S.
    Cerny, Th.
    Frueh, M.
    Hitz, F.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (06) : 577 - 582
  • [44] Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor TCell (CART) Therapy in Diffuse Large B-Cell Lymphoma (DLBCL)
    Ehsan, Hamid
    Ahmed, Ferdous
    Moyo, Tamara K.
    Hu, Bei
    Jacobs, Ryan W.
    Pang, Yifan
    Park, Steven I.
    Shroff, Vishal
    Boseman, Victoria
    Beam, Travis
    Elder, Jennifer
    Ghosh, Nilanjan
    BLOOD, 2023, 142
  • [45] Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis
    Andrew Ip
    Alex Mutebi
    Tongsheng Wang
    Monika Jun
    Anupama Kalsekar
    Fernando Rivas Navarro
    Anthony Wang
    Rajesh Kamalakar
    Mariana Sacchi
    Brian Elliott
    Advances in Therapy, 2024, 41 : 1226 - 1244
  • [46] Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis
    Ip, Andrew
    Mutebi, Alex
    Wang, Tongsheng
    Jun, Monika
    Kalsekar, Anupama
    Navarro, Fernando Rivas
    Wang, Anthony
    Kamalakar, Rajesh
    Sacchi, Mariana
    Elliott, Brian
    ADVANCES IN THERAPY, 2024, 41 (03) : 1226 - 1244
  • [47] Real-world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis
    Yang, Ping
    Cai, Qing-qing
    Zhang, Wei
    Liu, Shuo-zi
    Liu, Hui
    Sun, Xiu-hua
    Dong, Yu-jun
    Xiao, Xiu-bin
    Wang, Jing-wen
    Li, Zhen-ling
    Huang, Wen-rong
    Li, Li-hong
    Bao, Hui-zheng
    Yang, Wei
    Wang, Ya-lan
    Wang, Shu-ye
    He, Juan
    Li, Xiao-ling
    Liu, Ai-chun
    Jing, Hong-mei
    CANCER MEDICINE, 2023, 12 (12): : 13204 - 13216
  • [48] Real-World Challenges of Managing Diffuse Large B-Cell Lymphoma in a Developing Country
    Iftikhar, Raheel
    Ahmad, Usman
    Haider, Ghulam
    Mahmood, Humera
    Khan, Maryam
    Masood, Misbah
    Anwar, Nida
    Javed, Qamar
    Sajid, Nadia
    Tariq, Rija
    Mehmod, Sana
    Haider, Javeria
    Abro, Nargis Aalam
    Shahbaz, Shanzah
    Khokhar, Abbas
    Khan, Zeeshan Ahmed
    Pervez, Hassan
    Moosajee, Munira
    Aziz, Zeba
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [49] Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data
    Atesoglu, Elif Birtas
    Gulbas, Zafer
    Uzay, Ant
    Ozcan, Muhit
    Ozkalemkas, Fahir
    Dal, Mehmet Sinan
    Kalyon, Hakan
    Akay, Olga Meltem
    Deveci, Burak
    Bekoz, Huseyin
    Sevindik, Omur Gokmen
    Toptas, Tayfur
    Yilmaz, Fergun
    Koyun, Derya
    Alkis, Nihan
    Alacacioglu, Inci
    Sonmez, Mehmet
    Yavasoglu, Irfan
    Tombak, Anil
    Mehtap, Ozgur
    Kurnaz, Fatih
    Yuce, Orhan Kemal
    Karakus, Volkan
    Turgut, Mehmet
    Kurekci, Derya Deniz
    Ayer, Mesut
    Keklik, Muzaffer
    Buyuktas, Deram
    Ozbalak, Murat
    Ferhanoglu, Burhan
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (04) : 663 - 673
  • [50] Real-world patient characteristics, acute medication use, and treatment patterns for patients initiating fremanezumab treatment: A US retrospective claims analysis
    Buse, D. C.
    Seminerio, M. J.
    Thompson, S. F.
    Cohen, J. M.
    Tangirala, K.
    Ariely, R.
    Rubin, A.
    Carr, K.
    HEADACHE, 2021, 61 : 72 - 73
12345